bexarotene has been researched along with Anaplastic Large-Cell Lymphoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acebo-Mariñas, E; Aperribay-Esparza, A; de Quintana-Sancho, A; Gardeazabal-García, J | 1 |
| Alves, R; Fernandes, I; Lima, M; Oliveira, A; Selores, M | 1 |
| Bertsch, HP; Mitteldorf, C; Neumann, C; Stadler, R | 1 |
3 other study(ies) available for bexarotene and Anaplastic Large-Cell Lymphoma
| Article | Year |
|---|---|
Cerebral involvement as the first extracutaneous manifestation of mycosis fungoides.
Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Brain; Carmustine; Combined Modality Therapy; Cytarabine; Disease Progression; Fatal Outcome; Female; Humans; Lymphoma, Large-Cell, Anaplastic; Memory Disorders; Methotrexate; Middle Aged; Mycosis Fungoides; Nystagmus, Pathologic; PUVA Therapy; Skin Neoplasms; Tetrahydronaphthalenes | 2015 |
Primary cutaneous CD30 positive anaplastic large cell lymphoma--report of a case treated with bexarotene.
Topics: Anticarcinogenic Agents; Bexarotene; Female; Humans; Ki-1 Antigen; Lymphoma, Large-Cell, Anaplastic; Middle Aged; Neoplasm Recurrence, Local; Skin Neoplasms; Tetrahydronaphthalenes; Treatment Outcome | 2011 |
Folliculotropic mycosis fungoides with CD30+ large-cell transformation in a young woman: beneficial effect of bexarotene.
Topics: Adolescent; Antineoplastic Agents; Bexarotene; Female; Follow-Up Studies; Humans; Lymphoma, Large-Cell, Anaplastic; Mycosis Fungoides; Skin Neoplasms; Tetrahydronaphthalenes | 2007 |